Arcus Biosciences, Inc. (RCUS)

NYSE: RCUS · Real-Time Price · USD

8.80

+0.52 (6.28%)

At close: May 12, 2025, 4:00 PM

8.87

+0.07 (0.80%)

After-hours: May 12, 2025, 7:59 PM EDT

Arcus Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Revenue	141	258	117	112	383	78	Upgrade
Revenue Growth (YoY)	-40.51%	120.51%	4.46%	-70.76%	391.03%	420.00%	Upgrade
Cost of Revenue	461	448	340	288	257	159	Upgrade
Gross Profit	-320	-190	-223	-176	126	-81	Upgrade
Selling, General & Admin	116	120	117	104	72	43	Upgrade
Operating Expenses	116	120	117	104	72	43	Upgrade
Operating Income	-436	-310	-340	-280	54	-124	Upgrade
Interest Expense	-4	-4	-2	-2	-	-	Upgrade
Interest & Investment Income	50	52	41	16	1	1	Upgrade
EBT Excluding Unusual Items	-390	-262	-301	-266	55	-123	Upgrade
Asset Writedown	-	-20	-	-	-	-	Upgrade
Pretax Income	-390	-282	-301	-266	55	-123	Upgrade
Income Tax Expense	1	1	6	1	2	-	Upgrade
Net Income	-391	-283	-307	-267	53	-123	Upgrade
Net Income to Common	-391	-283	-307	-267	53	-123	Upgrade
Shares Outstanding (Basic)	93	90	74	72	69	55	Upgrade
Shares Outstanding (Diluted)	93	90	74	72	74	55	Upgrade
Shares Change (YoY)	20.51%	21.76%	2.78%	-2.70%	35.04%	25.04%	Upgrade
EPS (Basic)	-4.20	-3.14	-4.15	-3.71	0.76	-2.24	Upgrade
EPS (Diluted)	-4.20	-3.14	-4.15	-3.71	0.71	-2.24	Upgrade
Free Cash Flow	-303	-176	-330	432	-282	108	Upgrade
Free Cash Flow Per Share	-3.25	-1.95	-4.46	6.00	-3.81	1.97	Upgrade
Gross Margin	-226.95%	-73.64%	-190.60%	-157.14%	32.90%	-103.85%	Upgrade
Operating Margin	-309.22%	-120.15%	-290.60%	-250.00%	14.10%	-158.97%	Upgrade
Profit Margin	-277.31%	-109.69%	-262.39%	-238.39%	13.84%	-157.69%	Upgrade
Free Cash Flow Margin	-214.89%	-68.22%	-282.05%	385.71%	-73.63%	138.46%	Upgrade
EBITDA	-426	-300	-332	-274	58	-121	Upgrade
EBITDA Margin	-	-116.28%	-283.76%	-244.64%	15.14%	-155.13%	Upgrade
D&A For EBITDA	10	10	8	6	4	3	Upgrade
EBIT	-436	-310	-340	-280	54	-124	Upgrade
EBIT Margin	-	-120.15%	-290.60%	-250.00%	14.10%	-158.97%	Upgrade
Effective Tax Rate	-	-	-	-	3.64%	-	Upgrade
Revenue as Reported	141	258	117	112	383	78	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q